Zydus Lifesciences informs about press release

07 Nov 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated November 7, 2022, titled ‘Zydus receives EIR with Voluntary Action Indicated (VAI) from USFDA for its Moraiya manufacturing facility’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

865.00 -2.80 (-0.32%)
19-Jan-2026 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.25
Dr. Reddys Lab 1171.50
Cipla 1390.90
Zydus Lifesciences 865.00
Lupin 2187.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×